Methylenetetrahydrofolate Reductase Gene Polymorphism, Hyperhomocysteinemia, and Cardiovascular Diseases in Chronic Hemodialysis Patients

Publisher： Karger

E-ISSN： 2235-3186|90|1|43-50

ISSN： 1660-8151

Source： Nephron, Vol.90, Iss.1, 2001-12, pp. : 43-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Common Mutations C677T and A1298C in the Human Methylenetetrahydrofolate Reductase Gene Are Associated with Hyperhomocysteinemia and Cardiovascular Disease in Hemodialysis Patients

By  

Nephron, Vol. 92, Iss. 1, 2002-08 ,pp. : 120-126

Karger

Access to resources Recommend Favorite

Polymorphism in Methylenetetrahydrofolate Reductase Gene: Its Impact on Plasma Homocysteine Levels and Carotid Atherosclerosis in ESRD Patients Receiving Hemodialysis

By  

Nephron, Vol. 87, Iss. 3, 2001-03 ,pp. : 249-256

Karger

Access to resources Recommend Favorite

Methylenetetrahydrofolate Reductase Gene C677T Polymorphism, Plasma Homocysteine and Folate in End-Stage Renal Disease Dialysis and Non-Dialysis Patients

By  

Nephron, Vol. 92, Iss. 1, 2002-08 ,pp. : 235-239

Karger

Access to resources Recommend Favorite

CCN2 (CTGF) Gene Polymorphism Is a Novel Prognostic Risk Factor for Cardiovascular Outcomes in Hemodialysis Patients

By  

Blood Purification, Vol. 30, Iss. 4, 2010-11 ,pp. : 272-276

Karger

Access to resources Recommend Favorite

Mesna for the Treatment of Hyperhomocysteinemia in Hemodialysis Patients

By  

Blood Purification, Vol. 27, Iss. 3, 2009-03 ,pp. : 306-310

Karger

Access to resources Recommend Favorite